Skip to content
OpenCapital
Get started

NuSkin Enterprises NUS Proceeds from disposition of marketable securities and other investments

Proceeds from disposition of marketable securities and other investments at other companies

Community Health Systems logo
Community Health SystemsCYH
$45M+95.7%
CBIZ logo
CBIZCBZ
$3.64M-56.7%
AMN Healthcare logo
AMN HealthcareAMN
$2.51M-65.4%
GCM Grosvenor Inc. logo
GCM Grosvenor Inc.GCMG
$2.61M-56.0%
Zumiez logo
ZumiezZUMZ
$2.54M-50.0%
ATN International logo
ATN InternationalATNI
$216.25K+47.1%

Other financials

Income statement

See full
Revenue$320.6M-12.0%
Gross profit$214.5M-13.2%
Operating income$4.0M+141%
Net income$1.8M-98.3%
EPS (diluted)$0.04-98.1%

Balance sheet

See full
Cash & equivalents$198.7M-2.5%
Total debt$303.6M-8.2%
Total equity$794.1M+5.3%
Total assets$1.4B-1.1%

Cash flow

See full
Operating cash flow-$3.9M-1,107%
CapEx$13.7M+1.0%
Free cash flow-$17.6M-33.6%

Valuation

See full
Market cap$256.35M-38.2%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's proceeds from disposition of marketable securities and other investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NuSkin Enterprises's proceeds from disposition of marketable securities and other investments?
NuSkin Enterprises (NUS) reported proceeds from disposition of marketable securities and other investments of $0 in Q1 2026.
How has NuSkin Enterprises's proceeds from disposition of marketable securities and other investments changed year-over-year?
NuSkin Enterprises's proceeds from disposition of marketable securities and other investments decreased by 100.0% year-over-year, from $1.4M to $0.
What is the long-term trend for NuSkin Enterprises's proceeds from disposition of marketable securities and other investments?
Over 3 years (2021 to 2024), NuSkin Enterprises's proceeds from disposition of marketable securities and other investments has grown at a 6.8% compound annual growth rate (CAGR), from $15.09M to $18.38M.